RPS9 promotes the progression of NSCLC via activation Stat3 and Erk signaling pathways

Background: Non-small cell lung cancer (NSCLC) accounts for the largest pathological type of lung cancers, and it is characterized by high incidence and poor prognosis. However, the molecular mechanisms involved in development and progression of NSCLC are not well elucidated. In this study, we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Yiru, Shuangshuang, Deng, Liang, Xiaohua, Zhou, Xinli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899376/
https://www.ncbi.nlm.nih.gov/pubmed/35281852
http://dx.doi.org/10.7150/jca.67513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899376/
https://www.ncbi.nlm.nih.gov/pubmed/35281852
http://dx.doi.org/10.7150/jca.67513

Ejemplares similares